ContractRegistration Rights Agreement • May 15th, 2018 • SELLAS Life Sciences Group, Inc. • Pharmaceutical preparations • New York
This REGISTRATION RIGHTS AGREEMENT (as it may be amended from time to time in accordance with the terms hereof, the “Agreement”), dated as May 14, 2018, is made by and among SELLAS Life Sciences Group, Inc., a Delaware corporation (the “Company”) and Equilibria Capital Management Limited, a Bermuda limited liability company; EQC Private Markets SAC Fund II Ltd-EQC Biotech Sely S Fund, a Bermuda mutual fund company; EQC Private Markets SAC Fund Ltd-EQC Biotech Sely I Fund, a Bermuda mutual fund company; EQC Private Markets SAC Fund Ltd-EQC Biotech Sely II Fund, a Bermuda mutual fund company; EQC Private Markets II SAC Fund Ltd-EQC Biotech Sely III Fund, a Bermuda mutual fund company; and Varibobi Financial Holdings Ltd., a Cyprus limited company and Daniel Tafur, an individual (together with their Permitted Transferees that become party hereto, the “Investors”).
